Tag: chemotherapy
- ALK Experts
- ALK International
- ALK Positive News
- Clinical Trials
- Government
- Living with ALK+
- Nutrition
- Patient & Care Partner Stories
- Powered By Patients
- Recipes
- Research
-
Living Both Sides of Lung Cancer: Dr. Ross Camidge Returns to ALKtALK
Dr. Ross Camidge, Director of Thoracic Oncology at the University of Colorado Cancer Center, has been a trusted voice and sought-after second opinion for lung cancer patients around the world for decades. He has spoken at ALK Positive Summits, appeared on multiple ALKtALKs, and serves on the ALK Positive Scientific Advisory Board- guiding and supporting…
-
ALKtALK: Dr. Angel Qin
Join the one and only Dr. Angel Qin, thoracic oncologist at the University of Michigan and member of the ALK Positive Scientific Advisory Board, this Sunday at 7 PM ET. We will take a deep dive into the new Gilteritinib trial, sponsored by Astellas Pharma Inc., and what this new trial could mean for the…
-
Medical Committee Update
Join us for ALKtALK with Shirish Gadgeel, MD, and gain a deeper understanding of the essential role chemotherapy plays in ALK-positive cancer care.
-
The wait is over— Season 6 of ALKtALK begins with Dr. Christine Lovly.
Join us for ALKtALK with Shirish Gadgeel, MD, and gain a deeper understanding of the essential role chemotherapy plays in ALK-positive cancer care.
-
Dr. Shirish Gadgeel
Join us for ALKtALK with Shirish Gadgeel, MD, and gain a deeper understanding of the essential role chemotherapy plays in ALK-positive cancer care.
-
Ryohei Katayama, Ph. D.
Join ALKtALK for discussion on targeted therapy resistance with Dr. Katayama – Cancer Chemotherapy Center, JFCR.
-
The use of traditional chemotherapy in lung cancer
Many of us are on a tyrosine kinase inhibitor (TKI), however there are definite benefits to the use of traditional chemotherapy (chemo). In this article, we will learn a little more about this treatment option. Chemo may be recommended by your doctor in different situations: In stages I-III only: Before surgery (neoadjuvant chemotherapy): Neoadjuvant…